Abstract. The interaction of pyridine-4(-3,-2)aldoxime has been studied whit 3-bromo-N,N,N-trialkyl-2-oxo(-hydroxyimino)-1-propanaminium bromide. The structure of all synthesized compounds was determined by elemental analysis as well as by physical and chemical methods. All synthesized compounds were tested for reactivation of phosphorylated acetylcholinesterase. Using fragments of the molecules (an oxime group, 3-bromo-N,N,N-trimethyl(or triethyl)ammonium [(or N-methylmorpholinium)-2-oxo(or 2-hydroxyimino)]propan bromides), a new series of pyridinium-aldoxime salt (cholinesterase reactivator) was obtained.
Introduction
An important direction of modern chemistry is to find new compounds for development of drugs for the treatment of acute poisonings including very dangerous organophosphate (PO) poisonings [1] [2] [3] . Therefore, of great importance among biologically active compounds are reactivators of phosphorylated acetylcholinesterase (AChE) -known bis-quaternary salts of pyridinealdoxime, as well as methods for their preparation [4] . Quaternary salts of pyridine-aldoxime are a promising group of compounds for the treatment of organophosphate intoxication [4] [5] [6] [7] [8] [9] [10] [11] . Such salts can then be used for the treatment of cholinesterase inhibitors effect [5] [6] [7] [8] 12] . Reactivators of phosphorylated AChE (e.g. pralidoxime, HI-6, obidoxime, trimedoxime 1-4; Fig. 1 ) are commonly used in the treatment of organophosphate intoxication [2, 6] . They contain a nucleophilic oxime group capable of cleaving the phosphorylated fragment AChE and restoring the function of the enzyme [13] .
Presently known reactivators of phosphorylated AChE have several defects. These include high toxicity, low stability and limited antidote activity in poisonings by various types of organophosphorus agents, including sarin, soman and VX. Thus, changes in the active site of AChE caused by the action of GA are leading to partial deactivation of the toxicity compared to the oxime 2 [2] . This article presents a synthesis of quaternary salts of pyridine-aldoxime containing N,N,N-trialkyl-2-oxo-1-propanammonium fragment and its modification to N,N,N-trialkyl-2-(hidroxyimino)-1-propanammonium fragment (Fig. 2 ). This fragment is close to the structure of the choline moiety of acetylcholine that active center so that only some reactivators (3, 4) can resist this effect [2] However oximes 3 and 4 show an increased can enhance reactivation of phosphorylated cholinesterase in lesions of various types of PO compounds. Reactivation activity of the synthesized compounds was determined in vitro on enzyme preparations -human blood erythrocyte acetylcholinesterase with specific activity of 2.9 U/ml, suppressed by organophosphorus agent VX by 95-99.9 %, and evaluated by the largest concentration of the compound at which reactivation of phosphorylated enzyme by 50 % takes place, by the method [14] .
Experimental

Experimental Chemistry
The 1 H NMR spectra were recorded by "Tesla BS-485, Bruker" (80 MHz, 200 MHz) spectrometer in a DMSO-d6 using tetramethylsilane (TMS) as an internal standard (chemical shift values are reported in ppm units, coupling constants J are in Hz). Abbreviations are as follows: s -singlet; d -doublet; t -triplet; m -multiplet. IR spectra (pellets KBr) were recorded by the "Perken Elmer" instrument. Progress of the reaction and purity of the synthesized compounds are monitored by thin-layer chromatography on "Silufol UV-254" sheets in the system of n-propanol : acetate acid : water = 5:2:5. All solvents and reagents were used after additional purification. Melting points were measured on a smallsized heating table with РНМК 05 device (VEB Analytik, Dresden). 
Synthesis
4-[3-[4-[(Hydroxyimino)methyl]-1-pyridiniumyl]-2-oxopropyl]-4-methyl-morpholinium dibromide (8e
4-[(Hydroxyimino)methyl]-1-[2-(hydroxyimino)-3-(triethylammonium)propyl]-pyridinium dibromide ( 8j).
Yield 34 %, m.p. 451-453 K (i-PrOH), (R f •100) 13 (nPrOH:AcOH:H 2 O, 5:2:5). Anal.calcd. for C 15 
3-[(Hydroxyimino)methyl]-1-[2-(hydroxyimino)-3-(triethylammonium)propyl]-pyridinium dibromide (8k
Biological Activity
Reactivation of phosphylated cholinesterases by oximes 8 а-k
In vitro reactivation ability at the concentration of oximes C (10 -5 -10 -3 M/l) was studied in human erythrocytes cholinesterase from phosphorylation VX. The reduced enzyme activity was determined (in percent) at 310 K, pH 7.8 for 30 min. The method of continuous potentiometric titration of acetate acid formed during the hydrolysis of acetylcholine (Ach•HCl) solution of alkali (NaOH, 0.05 M) at a constant temperature of 310 K and pH 7.8 was used. The enzyme activity was determined by potentiometric method [14, 15] .
For calculation of the enzyme activity we determined slope angles of alkali consumption depending on hydrolysis time of ACh (ΔV/Δt).
Calculation of the reactivators relative ability in concentration C is performed using the formula: -3 M/l and the largest concentration of compound that restores the depressed enzyme activity by 50 % for 30 h, 310 K and pH 7.8. According to the schedule of reactivation ability (A, %) dependence on the concentration C, parameter C50 was determined. In Table  1 the index of reactivation ability of the synthesized compounds is presented.
Determining reactivation ability in vitro
Reactivation ability was determined at human acetylcholinesterase (specific activity 2.9 Е/ml). Acetylcholine chloride (initial concentration 2 • 10 -2 М) was determined for substrate. Enzyme has been deactivated by inhibitor VX (10 -1 М) by 95-99 %. The inhibitor was incubated with a solution of acetylcholinesterase (3 mg/ml) in phosphate buffer (1/15 M) for 3 min at 298 K. Excess of inhibitor is removed by dialysis in phosphate buffer (1/15 M, pH 7.6). Solutions of tested compounds are prepared in ethanol (initial concentration 2•10 -3 М). Working concentration of tested compounds is prepared by the method of cultivation by the phosphatic buffer.
8 ml of water, 1 ml of KCl (0.1 N), 0.4 ml substrate (2•10 -2 M), 0.6 ml sample: 0.3 ml phosphylated acetylcholinesterase, and 0.3 ml reactivator (tested compound) in phosphate buffer (pH 7.8, 1/15 M) were placed in a thermostated cuvette. Total reaction volume was 10 ml. 
Biological Activity
Reactivation ability of the salts 8a-f is largely determined by the position of hydroxyiminomethyl group in the pyridine ring. Investigated compounds 8a,g,h,k and 8b,c,d ,e,f,j display maximum reactivation activity at the concentrations of 0.001 and 0.0005 М/l, respectively (Fig. 3) . Compounds 8а,с,е reduced activity of phosphorylated acetylcholine esterase by А > 50 %. Activity of compounds 8а,с,е is higher than activity of trimedoxime. Dependence of reactivation activity of the compounds on the concentration is shown in Figs. 4 and 5. For compounds 8а,с,е kinetic parameters (рС50, pKr), which characterize the process of reactivation (Krreactivators efficiency ratio in the equilibrium stage at concentration of reactivators 1 М and n = [pKr/рС50] -Hill coefficient) can be determined. For this we studied the dependence of the p(100-A)/A from pC (Fig. 6) . On the basis of approximating curve (linear) of each of the dependencies, corresponding kinetic parameters were received (Table 2 ) graphically or by calculations (Eqs. (1-3) ). 
Conclusions
A simple method for the synthesis of pyridiniumaldoxime salts 8a-k by alkylation reaction of pyridinealdoxime from bromides, containing 3-bromo-N,N,Ntrialkyl-2-oxo(or 2-hydroxyimino)-1-propanammonium fragments was developed. All synthesized compounds were tested for reactivation of phosphorylated acetylcholinesterase. Using fragments of the molecules (an oxime group, 3-bromo-N,N,N-trimethyl (or triethyl) ammonium bromides (or N-methyl-morpholinium)-2-oxo-or 2-hydroxyimino)-1-propane bromides), a new series of pyridinium-aldoxime salt (reactivators of cholinesterase) was obtained. 
